Figure 1.
Figure 1. OS, PFS, CIR, and NRM following HSCT in patients previously treated with a PD-1 inhibitor. (A) OS, (B) PFS, (C) CIR, and (D) NRM.

OS, PFS, CIR, and NRM following HSCT in patients previously treated with a PD-1 inhibitor. (A) OS, (B) PFS, (C) CIR, and (D) NRM.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal